Movement Alert|Nike Declines 3.05% Overnight, Weak FY2027 Guidance Overshadows Q4 Earnings Beat

Market Focus
Jul 01

On July 1, Nike declined 3.05% overnight, trading at $39.85/share, with turnover of $943,400. The stock fell in after-hours trading following the release of fiscal Q4 results, as forward guidance disappointed investors despite a top- and bottom-line beat.

Nike reported fiscal Q4 revenue of $10.97 billion, down 1.1% year-over-year but slightly above the $10.86 billion consensus. Adjusted EPS came in at $0.72, well ahead of the $0.13 estimate, with net income surging 407% year-over-year — though largely driven by a one-time tariff refund benefit. Greater China revenue fell 12%, emerging as the primary drag on overall performance. Critically, management guided FY2027 full-year revenue to decline by low-to-mid single digits, sharply below the market expectation of 0.4% growth.

CEO Elliott Hill stated the company faces additional pressure from declining global foot traffic and weakening discretionary spending, while the CFO acknowledged that the operating environment grew more challenging during Q4. Despite bright spots in running — which posted a fifth consecutive quarter of double-digit growth — sportswear and Jordan lifestyle categories remain under pressure, with management warning the first half of FY2027 will see continued revenue declines.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10